Colgate-Palmolive Company (CL)
NYSE: CL · Real-Time Price · USD
88.23
+0.04 (0.05%)
Jan 21, 2025, 4:00 PM EST - Market closed
Colgate-Palmolive Company Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for CL stock have an average target of 101.11, with a low estimate of 83 and a high estimate of 112. The average target predicts an increase of 14.60% from the current stock price of 88.23.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CL stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 6 | 6 | 6 | 6 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 6 | 6 | 7 | 7 | 7 | 7 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $101 → $95 | Hold | Maintains | $101 → $95 | +7.67% | Jan 17, 2025 |
| Barclays | Barclays | Hold Maintains $96 → $83 | Hold | Maintains | $96 → $83 | -5.93% | Jan 17, 2025 |
| UBS | UBS | Strong Buy Maintains $112 → $104 | Strong Buy | Maintains | $112 → $104 | +17.87% | Jan 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $109 → $103 | Buy | Maintains | $109 → $103 | +16.74% | Jan 16, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $110 → $100 | Strong Buy | Maintains | $110 → $100 | +13.34% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
20.78B
from 19.46B
Increased by 6.82%
Revenue Next Year
21.36B
from 20.78B
Increased by 2.75%
EPS This Year
3.70
from 2.77
Increased by 33.64%
EPS Next Year
3.97
from 3.70
Increased by 7.25%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 21.3B | 22.2B | 23.3B | |||
| Avg | 20.8B | 21.4B | 22.2B | |||
| Low | 19.7B | 19.9B | 20.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.3% | 7.0% | 8.9% | |||
| Avg | 6.8% | 2.8% | 4.1% | |||
| Low | 1.2% | -4.3% | -3.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.89 | 4.15 | 4.63 | |||
| Avg | 3.70 | 3.97 | 4.31 | |||
| Low | 3.50 | 3.69 | 3.97 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 40.3% | 12.0% | 16.6% | |||
| Avg | 33.6% | 7.3% | 8.4% | |||
| Low | 26.3% | -0.2% | 0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.